Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Revance Therapeutics, Inc. (RVNC)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Revenues:  
    DAXXIFY®  22.6       
    Service  3.73.62.01.20.90.50.30.7
    Product  54.445.827.125.524.425.519.418.4
    Other     1.7    
Total revenues  58.149.329.028.425.326.019.718.8
            Revenue growth   [+]104.9%95.3%46.9%50.9%89.9%133.1%414.9%6189.0%
Cost of goods sold   [+]21.316.2110.49.57.991.396.292.8
Gross profit  36.833.2-81.418.817.4-65.4-76.4-74.0
            Gross margin  63.3%67.2%-280.4%66.4%68.8%-251.9%-387.1%-393.6%
Selling, general and administrative   [+]77.466.065.847.845.146.452.850.6
Research and development  22.823.226.124.930.729.530.129.4
Other operating expenses    -95.8  -79.7-86.6-83.7
EBITDA   [+]-62.0-51.4-72.0-51.2-56.8-56.2-67.6-65.3
            EBITDA margin  -106.6%-104.2%-248.3%-180.6%-225.0%-216.5%-342.2%-347.2%
Depreciation  -3.36.61.3-3.35.41.31.00.9
EBITA  -58.7-58.0-73.3-47.9-62.2-57.4-68.6-66.2
            EBITA margin  -101.0%-117.6%-252.7%-169.0%-246.3%-221.4%-347.2%-351.8%
Amortization of intangibles  6.8 4.29.9 4.24.24.2
EBIT   [+]-65.5-58.0-77.5-57.8-62.2-61.6-72.7-70.3
            EBIT margin  -112.7%-117.6%-267.0%-203.9%-246.3%-237.4%-368.3%-374.1%
Interest expense, net   [+]1.21.55.83.31.91.51.51.5
Other income (expense), net   [+]-0.6-0.2-1.5-0.3-0.30.0-0.2-0.4
Pre-tax income  -67.3-59.8-84.7-61.4-64.3-63.1-74.4-72.2
Income taxes  0.00.0-0.70.00.00.00.00.0
            Tax rate  0.0%0.0%0.8%0.0%0.0%0.0%0.0%0.0%
Net income  -67.3-59.8-84.7-61.4-64.3-63.1-74.4-72.2
            Net margin  -115.8%-121.2%-291.9%-216.6%-254.7%-243.2%-376.7%-383.9%
   
Basic EPS   [+]($0.80)($0.74)($1.17)($0.88)($0.94)($0.93)($1.10)($1.07)
Diluted EPS   [+]($0.80)($0.74)($1.17)($0.88)($0.94)($0.93)($1.10)($1.07)
   
Shares outstanding (basic)   [+]83.781.172.270.168.367.567.867.5
Shares outstanding (diluted)   [+]83.781.172.270.168.367.567.867.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy